- Pegylovaný interferon beta-1a v klinické praxi2018 | Second Faculty of Medicine
- Depression and treatment with beta-interferon in multiple sclerosis2014 | Faculty of Medicine in Pilsen
- Interferons2009 | First Faculty of Medicine
- Interferon Beta Therapy Initiation at an Inappropriate Phase of the Disease2013 | First Faculty of Medicine
- Interferon beta in the current treatment of multiple sclerosis2013 | First Faculty of Medicine
- Interferons-β treatment during pregnancy and breast-feeding2020 | Second Faculty of Medicine
- Interferon Beta Therapy in a Patient with Clinically Isolated Syndrome - a Case Report2013 | First Faculty of Medicine
- Pegylated inteferon beta 1-a in clinical routine2019 | Second Faculty of Medicine
- Monitoring of the Biological Effect of Interferon Beta in the Treatment of Multiple Sclerosis2013 | Second Faculty of Medicine
- Interpretation of neutralizing antibodies and myxovirus resitance protein A testing in patients with multiple sclerosis treated with interferon beta2014 | Second Faculty of Medicine
- Alpha administration as post-transplant immunotherapy in malignant lymphomas.1999 | Faculty of Physical Education and Sport
- Long-Term Treatment with Interferon Beta - a Case Report2013 | Faculty of Medicine in Hradec Králové
- Treatment intramuscular interferon beta-1a2013 | First Faculty of Medicine
- Monitoring of interferon beta bioactivity in the multiple sclerosis2011 | Second Faculty of Medicine
- Coping with flu-like symptoms and injection site reactions in the treatment subcutaneous interferon beta-1a od multiple sclerosis2014 | Faculty of Medicine in Pilsen
- Interferons and their use in haematology and oncology2003 | First Faculty of Medicine
- Interferon β and glatiramer acetate in the treatment of multiple sclerosis; new insights into their activities2014 | Faculty of Medicine in Hradec Králové
- Neutralising antibodies and Myxovirus resistance protein A as a marker of biological response to interferon β2014 | Second Faculty of Medicine
- Retreatment with peginterferon plus ribavirin in chronic hepatitis C patients: our own experiences2010 | Faculty of Science
- The Budd-Chiari syndrome in a patient with primary thrombocythemia treated with interferon alfa and transjugular portosystemic shunt2004 | Faculty of Medicine in Hradec Králové, Third Faculty of Medicine
- Treatment of the vision threating uveitis by interferon Alfa-2APublication without faculty affiliation
- Non-specific immunotherapy inhibits angiogenesis - results of the monitoring of serum levels of vascular endothelial growth factor and matrix metalloproteinase 8 in patients with malignant melanoma receiving adjuvant high-dose interferon therapy2017 | First Faculty of Medicine, Central Library of Charles University
- Interferon alpha in treatment of CML patients - resultsPublication without faculty affiliation
- Assessment of Incidence and Character of Neurologic/Neuropsychiatric Complications in a Group of Patients with Malignant Melanoma Treated with Adjuvant High Dose interferon2018 | Central Library of Charles University
- Interferon alpha in the treatment for advanced renal cell carcinoma2006 | Faculty of Medicine in Hradec Králové
- Interferon Alpha Treatment for Sight Threatening Posterior Uveitis - New ExperiencesPublication without faculty affiliation
- Tolerability of combine treatment with interferon beta and azathioprine in remitent MSPublication without faculty affiliation
- Interferon-alfa in the treatment of solid tumors (renal cell carcinoma and melanoma)2007 | Publication without faculty affiliation
- Interferon-alfa in the treatment of solid tumors (renal cell carcinoma and melanoma) +12007 | Faculty of Medicine in Hradec Králové